In the quest for a TBI therapy, astrocytes may be the bull’s-eye
New studies show what happens when an enzyme called monoacylglycerol lipase (MAGL) is genetically inactivated in experimental mice. Typically, MAGL breaks down a neuroprotective molecule
February 12, 2022
No Comments